Cargando…
PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions
Ovarian cancer is the fifth leading cause of female cancer deaths in the Western world. Significant progress has been made in the treatment of patients with ovarian cancer, however, the majority of patients experience disease recurrence and new therapies are being sought for such patients. Clinical...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816268/ https://www.ncbi.nlm.nih.gov/pubmed/26669450 http://dx.doi.org/10.1038/bjc.2015.395 |